Sphere Fluidics Launches Cyto-Cellect® Fc Fusion Assay Kit to Expedite Cell Line Development for Fusion Proteins News Sphere Fluidics Launches Cyto-Cellect® Fc Fusion Assay Kit to Expedite Cell Line Development for Fusion Proteins
Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America News Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America
Sphere Fluidics announces Cyto-Mine® Chroma to accelerate and streamline workflows News Sphere Fluidics announces Cyto-Mine® Chroma to accelerate and streamline workflows
Sphere Fluidics appoints Dr. Alex Dickinson as Non-Executive Director News Sphere Fluidics appoints Dr. Alex Dickinson as Non-Executive Director
Sphere Fluidics awarded gold accreditation by Investors in People News Sphere Fluidics awarded gold accreditation by Investors in People
Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024 News Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024
Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows News Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets News Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer News Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Sphere Fluidics appoints Edward Rayner as Non-Executive Director News Sphere Fluidics appoints Edward Rayner as Non-Executive Director
